Sanofi (SNY) stock gains as company exceeds Q3 earnings estimates with strong vaccine and Dupixent sales, and raises its full ...

Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted ...

French drug major Sanofi (SNYNF, SNY) reported third quarter net income attributable to equity holders of the company of 2.82 billion ...

(Bloomberg) -- PAI Partners has submitted an improved offer for Sanofi’s consumer health business ... Most Read from ...

PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier ...

(RTTNews) - Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving pregnant ...

Sanofi has returned with 300 million euros ($326 million) to set up a more permanent radioligand project. The new entity, which will operate under the Orano Med brand, will be focused on ...

C3.ai AI shares have returned 12.4% in the past month, outperforming the broader Zacks Computer and Technology sector’s ...

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...